毕得医药
(688073)
| 流通市值：22.21亿 | | | 总市值：46.68亿 |
| 流通股本：4323.42万 | | | 总股本：9088.29万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 552,129,577 | 1,105,333,099.8 | 889,356,898.34 | 957,626,154.2 |
| 应收票据及应收账款 | 253,520,428.95 | 227,367,484.42 | 234,764,760.95 | 231,936,108.98 |
| 其中：应收票据 | 4,645,968.02 | 4,413,544.96 | 5,454,926.74 | 678,937.9 |
| 应收账款 | 248,874,460.93 | 222,953,939.46 | 229,309,834.21 | 231,257,171.08 |
| 预付款项 | 12,597,609.98 | 6,237,236.85 | 10,011,832.71 | 10,188,862.08 |
| 其他应收款合计 | 13,975,485.63 | 15,389,852.81 | 12,583,694.24 | 10,137,632.37 |
| 存货 | 801,904,601.95 | 760,217,457.8 | 709,915,587.42 | 686,131,773.28 |
| 其他流动资产 | 16,018,014.51 | 18,655,955.37 | 21,572,996.71 | 16,100,310.08 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,707,237,377.89 | 2,208,723,169.25 | 2,160,696,619.69 | 2,177,018,736.88 |
| 非流动资产: | | | | |
| 长期股权投资 | 762,559,943.83 | - | - | - |
| 固定资产 | 97,977,187.13 | 100,688,680.83 | 35,389,227.52 | 37,619,691.25 |
| 在建工程 | 15,251,891.79 | 15,414,390.84 | 67,581,944.32 | - |
| 使用权资产 | 44,930,661.19 | 50,776,810.28 | 44,275,139.72 | 50,528,530.04 |
| 无形资产 | 3,834,058.56 | 3,945,455.07 | 4,089,293.15 | 4,215,432.05 |
| 长期待摊费用 | 22,158,776.95 | 23,741,714.52 | 26,465,301.41 | 29,515,978.22 |
| 递延所得税资产 | 15,322,035.53 | 14,744,897.61 | 13,667,887.09 | 15,248,654.73 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 962,034,554.98 | 209,311,949.15 | 191,468,793.21 | 137,128,286.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,669,271,932.87 | 2,418,035,118.4 | 2,352,165,412.9 | 2,314,147,023.17 |
| 流动负债: | | | | |
| 短期借款 | 252,480,344.12 | 30,182,470.22 | 58,390,582 | 37,645,305.32 |
| 交易性金融负债 | 165,744.91 | - | - | - |
| 应付票据及应付账款 | 230,869,202.01 | 216,321,149.07 | 179,513,995.38 | 181,243,788.02 |
| 其中：应付票据 | 218,750 | 218,750 | - | - |
| 应付账款 | 230,650,452.01 | 216,102,399.07 | 179,513,995.38 | 181,243,788.02 |
| 合同负债 | 36,998,885.55 | 36,686,165.31 | 24,897,935.43 | 23,646,764.87 |
| 应付职工薪酬 | 20,956,546.29 | 18,784,656.62 | 17,748,391.87 | 16,288,053.42 |
| 应交税费 | 36,393,787.85 | 25,513,090.52 | 18,361,588.8 | 18,015,301.05 |
| 其他应付款合计 | 101,269.92 | 339,146.95 | 480,167.77 | 540,304.51 |
| 一年内到期的非流动负债 | 12,206,121.89 | 14,064,552.02 | 13,966,526.3 | 16,104,506.75 |
| 其他流动负债 | 3,520,328.5 | 3,870,092.89 | 2,648,003.56 | 2,530,487.57 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 593,692,231.04 | 345,761,323.6 | 316,007,191.11 | 296,014,511.51 |
| 非流动负债: | | | | |
| 租赁负债 | 35,575,555.58 | 37,954,848.68 | 31,011,406.1 | 35,096,786.17 |
| 递延所得税负债 | 6,633,269.65 | 7,196,482.48 | 7,173,887.25 | 7,873,258.44 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 42,208,825.23 | 45,151,331.16 | 38,185,293.35 | 42,970,044.61 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 635,901,056.27 | 390,912,654.76 | 354,192,484.46 | 338,984,556.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 90,882,948 | 90,882,948 | 90,882,948 | 90,882,948 |
| 资本公积 | 1,762,815,872.13 | 1,755,202,764.04 | 1,754,611,520.07 | 1,754,240,743.08 |
| 减:库存股 | 132,773,622.3 | 99,991,734.5 | 99,991,734.5 | 87,420,246.76 |
| 其他综合收益 | -7,879,201.26 | -8,603,300.81 | -3,589,321.33 | -6,585,665.22 |
| 盈余公积 | 29,714,563.31 | 29,714,563.31 | 27,497,479.99 | 27,497,479.99 |
| 未分配利润 | 290,610,316.72 | 259,917,223.6 | 228,562,036.21 | 196,547,207.96 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,033,370,876.6 | 2,027,122,463.64 | 1,997,972,928.44 | 1,975,162,467.05 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,033,370,876.6 | 2,027,122,463.64 | 1,997,972,928.44 | 1,975,162,467.05 |
| 负债和股东权益合计 | 2,669,271,932.87 | 2,418,035,118.4 | 2,352,165,412.9 | 2,314,147,023.17 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-24 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |